Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Hidradenitis Suppurativa Surgery: Advances and Techniques

Description

The presentation on Hidradenitis Suppurativa (HS) surgery focuses on recent advancements and techniques for managing this challenging condition. The speaker introduces surgical definitions and differentiates between excisional surgery and de roofing, emphasizing the importance of a standardized terminology. They discuss the disease's progression, patient management strategies, and the benefits of using laser treatments, especially for patients with numerous nodules and minimal sinus tunnels. Techniques like CO2 laser surgery with tumescent anesthesia are highlighted, showcasing their efficacy in providing pain relief and promoting better surgical outcomes. The speaker shares insights on the importance of achieving hemostasis and detailed wound care post-surgery, making it clear that patient education is critical for recovery. They provide data on recurrence rates and advocate for multidisciplinary approaches in treatment, linking surgical intervention with medical management and psychological support. The need for biopsies in suspicious lesions is stressed to avoid overlooking malignancies. Finally, the speaker expresses gratitude to collaborators and encourages attendance at upcoming HS forums to further advance understanding and treatment of the disease.

View more

Conclusions

  • The definitions of surgical procedures for hidradenitis suppurativa (HS) have been standardized through expert consensus to guide treatment.
  • Deroofing and wide excision surgeries are effective treatments for HS, with significantly lower recurrence rates when properly executed.
  • Using CO2 laser excision under tumescent anesthesia is associated with improved healing outcomes and lower recurrence rates as compared to traditional methods.
  • The use of adjunctive therapies like laser hair removal can reduce disease severity and frequency of painful flares in HS patients.
  • Multidisciplinary care significantly increases the chances of successful healing in HS patients, emphasizing the importance of collaboration across specialties.
  • Patients should be counseled on the nature of their disease and potential treatment outcomes, including recurrence chances, to set realistic expectations.
  • JAMA. 2017;318(20):2019-2032. doi:10.1001/jama.2017.16691
  • S Kirby, MD, MEd, MS; Drew Saylor, MD; Christopher Sayed, MD; Helen Bui, BS; Falk G. Bechara, MD; Ralph George, MD; Stephanie Goldberg, MD; Iltefat Hamzavi, MD; Joslyn S Kirby, MD, MEd, MS; Drew Saylor, MD; Christopher Sayed, MD; University of North Carolina School of Medicine, Chapel Hill, NC, USA; Ruhr-University, Department of Dermatologic Surgery, Bochum, Germany; University of Toronto, Department of Surgery, Toronto, Canada; Mary Washington Healthcare, Department of Surgery, Fredericksburg,
  • Kohorst J et al. Derm Surg. 2016
  • Tierney E, Hamzavi I et al. Derm Surg. 2009
  • Mahmoud I, Hamzavi I et al. JAAD. 2010
  • Xu I, Hamzavi I et al. Arch Derm. 2011
  • Hazen P. Derm Surg. 2010.
  • Bechara F et al. Nov 2021 Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: The SHARPS Randomized Clinical Trial JAMA surgery
  • Ezekwe N, Neelam R, Jones BA, Ozog DM, Hamzavi IH. CO2 excision therapy for hidradenitis suppurativa. J Am Acad Dermatol. 2023 Mar.
  • Ovadja Z Derm Surg Nov 2020
  • Maghfour W et al, submitted to BJD